Related Experiment Video
Updated: Mar 29, 2026

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
[Factitious diseases in oncology].
Michel Reich1, Amélie Clermont2, Éric Amela3
1Centre Oscar-Lambret, équipe de psycho-oncologie, 3, rue Frédéric-Combemale, BP 307, 59020 Lille cedex, France.
Factitious disorders, including Munchausen's syndrome, are rare and often misdiagnosed in oncology, leading to inappropriate treatments. Early recognition and collaboration with psychiatric teams are crucial for effective patient management.
Area of Science:
- Oncology
- Psychiatry
- Medical Psychology
Background:
- Factitious disorders and pathomimias, such as Munchausen's syndrome, are infrequently encountered in oncology settings.
- Their rarity contributes to significant diagnostic challenges for medical teams.
- Misdiagnosis can lead to severe consequences, including unnecessary surgeries and inappropriate chemotherapy or radiotherapy.
Observation:
- Patients with factitious disorders simulate illness to gain medical attention.
- These patients may exhibit belligerent behavior and self-discharge from hospitals if their simulated condition is not validated or if they are confronted.
- Key diagnostic indicators include a history of medical peregrination, conflicts with healthcare providers, prior psychiatric conditions, a background in healthcare, and social isolation.
Findings:
- The diagnosis and management of factitious disorders in oncology present considerable difficulties.
- Patients often deny the reality of their condition and may terminate contact with clinicians who identify the disorder.
- Collaboration between oncologists, surgeons, psycho-oncology, and consultation-liaison psychiatric teams is essential.
Implications:
- Oncologists and surgeons must maintain vigilance for factitious disorders.
- Multidisciplinary collaboration is vital for accurate diagnosis and appropriate patient care.
- Developing specific strategies for managing patients with factitious disorders is recommended to improve outcomes and prevent iatrogenic harm.
More Related Videos
09:52A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
Published on: September 20, 2016
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Abnormal Proliferation
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Prevention
Some...
Cancer